 | This article relies largely or entirely on a single source .(August 2019) |
 | |
 | |
| Clinical data | |
|---|---|
| Other names | B; 3,5-Dimethoxy-4-butoxyphenethylamine; 4-Butoxy-3,5-dimethoxyphenethylamine |
| Routes of administration | Oral [1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Several hours [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Buscaline (B), also known as 4-butoxy-3,5-dimethoxyphenethylamine, is a chemical compound prepared as a possible psychedelic drug. [1] It is an analogue of mescaline. Buscaline was first synthesized by Alexander Shulgin. [1] In his book PiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 150 mg, and the duration as "several hours". [1] Buscaline produced no clear hallucinogenic effects, but caused side effects like heart arrhythmia and light diarrhea. [1] It did not cause any visuals or insights. [1]
